The study presents the echinocandin susceptibility profile of a multi-centre collection of pathogenic yeast isolates from Romanian tertiary hospitals. The 562 isolates were identified using ID32C strips, MALDI-TOF MS and DNA sequencing. Minimal inhibitory concentrations (MICs) of caspofungin (CAS), micafungin (MCA), and anidulafungin (ANI) were assessed and interpreted according to EUCAST guidelines. Minimal fungicidal concentrations (MFC) were determined by plating content from the clear MIC wells. The activity was considered fungicidal at MFC/MIC ≤ 4. The three echinocandins had strongly correlated MICs and high percentages of MIC essential agreement. Most often, MCA had the lowest MICs, followed by CAS and ANI. Mares et al.
Introduction
The advancements in medical care sustain an increasing number of patients with impaired immunity, which are susceptible to opportunistic pathogens such as fungi. 1 Candida yeasts, the main fungal pathogens, are responsible for high medical care costs and high mortality rates. 2 Echinocandins are semisynthetic lipopeptides that block an enzyme complex from the fungal cell membrane, which is responsible for the synthesis of β-glucan, a major component of the cell wall of certain groups of fungi. As it is uniquely fungal, this therapeutic target is a major advantage of these antifungal agents. 3 Owing to their minimal interference with human metabolic pathways, echinocandins have a low toxicity and relatively few drug interactions compared with azoles. 4 Although they have a relatively narrow activity spectrum compared with other classes of antifungal agents, 4 echinocandins are very effective against both biofilms and planktonic Candida and Aspergillus, the most prevalent invasive fungal pathogens. 5, 6 They are therefore used more and more often as a first line of defence or for prophylaxis against invasive fungal infections. 7 Very low at first, the resistance rates to these antifungal agents are increasing because of the selective pressure produced by antifungal treatment. The resistance rates increase because naturally susceptible species acquire resistance inducing mutations, such as C. glabrata, 8 and because of shifts in species distributions toward yeasts with intrinsic target gene alterations, such as C. parapsilosis or C. guilliermondii. 9 Therefore, periodic surveys of antifungal efficacy are of great use in assessing the evolution of fungal susceptibility and adjusting therapeutic guidelines. 7 The present study describes the in vitro inhibitory and fungicidal activity of the three echinocandins currently used in antifungal therapy, that is, caspofungin (CAS), micafungin (MCA), and anidulafungin (ANI), against a large multicentre derived collection of pathogenic yeasts from Romania. It is a necessary and logical continuation of our study regarding the efficacy of azole antifungals. 10 The minimal inhibitory concentrations (MICs) and the minimal fungicidal concentrations (MFCs) were determined. A study of the relationship between the MICs and the MFCs is also included.
Methods

Yeast isolates
A number of 562 clinical isolates of yeasts were received from hospitals located in various parts of Romania, including Iaşi, Tîrgu Mureş, Timişoara, Cluj-Napoca, and Bucharest. The isolates were collected from both sterile and non-sterile sites within a time interval of three years, from 2012 to 2014. Most isolates from sterile sites came from bloodstream infections confirmed by blood cultures (174), but also from the upper urinary tract, the peritoneal cavity or the cerebrospinal fluid. The non-sterile collection sites included the oropharyngeal cavity (145), the female genital tract (91), the lower respiratory tract (70), the gastro intestinal tract (30) , and other peripheral infections. The pathogenic yeasts were necessarily associated with a range of risk factors: therapy with broad-spectrum antibiotics, central venous catheter, immunosuppression (HIV infection or other predisposing conditions), insulin-dependent diabetes mellitus, reduced weight at birth (<1500 g), mechanical ventilation, advanced age (>65 years), organ transplantation, extended ICU stay (>48h), recent major surgery or total parenteral nutrition. Only isolates from patients with at least two of the above risk factors were included in the study. Briefly, the yeast isolates were preliminary identified using ID32C strips (bioMérieux, France). The definitive species confirmation was done by using MALDI-TOF MS and DNA sequencing (i.e., for the C. parapsilosis complex, Saccharomyces spp., rare and cryptic yeast species, and any other isolate with inconclusive identity) 10 or duplex PCR (for C. dubliniensis), 11 were used.
In vitro antifungal susceptibility
The EUCAST EDef. Table 1 .
To analyze the fungicidal activity of the echinocandins, the isolates were distributed into 10 groups of antifungal activity, as depicted in Table 2 . The antifungal activity was considered fungicidal when MFC/MIC ≤ 4.
18 Echinocandins were not considered fungicidal when the MFC values were right-censored (MFC > 8 mg/l). Depending on their MIC and MFC values and on the log 2 dilution distances between the two values, there were five levels of fungicidal activity (groups 1-5) and five levels of nonfungicidal activity (groups 6-10). Statistical analysis was done with GraphPad Prism version 7 (GraphPad Software, La Jolla, California USA, www.graphpad.com). The susceptibility differences between the isolates collected from sterile sites and those collected from nonsterile sites were analyzed with the unpaired t test. The antifungal activity differences between the three echinocandins were analysed by performing the one-way analysis of variance (ANOVA) test with Tukey's correction for multiple comparisons. The correlation between the three echinocandins was assessed by calculating the Pearson correlation coefficients. Two-tailed P < .05 was considered significant. For calculation purposes, right-censored MIC or MFC values (>8 mg/l) were considered as the next theoretical concentration (16 mg/l).
Results
The lists of the identified species in the order of their number of isolates, overall and per type of collection site respectively, are presented in table S1 and table S2 (see supplementary files). The lower proportion of C. albicans and the higher proportion of C. parapsilosis in the isolates collected from normally sterile sites compared with the nonsterile sites stand out.
Distribution of MIC and MFC values
The descriptive statistical parameters for the MIC and MFC values are also presented in Table S1 and Table S2 . The strongest correlation occurred between the MICs of MCA and ANI (R 2 = 0.85, P < .0001), followed by CAS with MCA (R 2 = 0.78, P < .0001) and CAS with ANI (R 2 = 0.61, P < .0001). This reflected in the high percentages of MIC essential agreement (±1 log2 dilution difference): 95% for MCA vs. ANI, 91% for CAS vs. MCA, and 88% for CAS vs. ANI. Most often, the echinocandin with the lowest MIC values was MCA, followed by CAS, and ANI (P < .0001). This general trend applied to most species, 
Reduced susceptibility
The EUCAST BPs for echinocandins are also the ECOFF values for the same drug-bug combinations; therefore, the notions of resistant and NWT isolates overlap. Since most isolates were separated based on ECOFF or ECOFF-derived values, NWT isolates will be reported in the results. Overall, CAS had the lowest rate of NWT isolates, while ANI had the highest one. There were 66 isolates with high MICs to at least one echinocandin. Of these, 47 (8.4%) were resistant, based on BPs.
The number of CAS NWT isolates was relatively low and evenly distributed over the prevalent Candida species. More than half of the isolates with high MIC values for CAS belonged to the rare species of Candida or to the non-Candida group, where S. cerevisiae stands out with 6 isolates over 0.12 mg/l.
Regarding the activity of MCA, C. albicans, C. glabrata and C. kefyr had the highest numbers of NWT isolates, from the most prevalent species. The more rare Candida species and the non-Candida group had a significant number of isolates with high MICs (>0.12 mg/l).
The highest percentage of isolates with elevated MIC values occurred in the case of ANI. C. albicans, C. glabrata, C. krusei, C. tropicalis, C. kefyr, and C. dubliniensis had high proportions of NWT isolates. Again, the rare species had an important number of isolates with high MICs.
For isolates collected from normally sterile sites, the NWT rates were higher for CAS but lower for MCA and ANI. In both categories of isolates, ST and NST, the rare Candida species and the non-Candida species had high rates of isolates with MICs over 0.12 mg/l.
Most isolates (99%) that were WT for MCA and ANI, or for either of the two, were also WT for CAS. Of the isolates that were NWT for MCA, 71.4% were WT for CAS: 15 isolates of C. albicans, five of C. glabrata, three of C. kefyr, one of C. rugosa, and one of C. tropicalis. Of the isolates that were NWT for ANI, 80.8% were WT for CAS: 13 isolates of C. krusei, 12 of C. albicans, eight of C. glabrata, four of C. tropicalis, three of C. kefyr, one of C. rugosa, and one of C. lambica. Of the isolates that were NWT for MCA and ANI, 67.9% were WT for CAS, 12 isolates of C. albicans, five of C. glabrata, one of C. rugosa, and one of C. tropicalis.
Of the isolates that were NWT for MCA, 20.0% were WT for ANI: four isolates of C. albicans and three of C. kefyr. Of the isolates that were NWT for ANI, 49.1% were WT for MCA: 14 isolates of C. krusei, three of C. glabrata, three of C. tropicalis, three of C. kefyr, three of C. dubliniensis, and one of C. lambica.
There were 22 isolates that were resistant to fluconazole (FLC) and NWT for at least one echinocandin. Of these, 17 (3%) were resistant to echinocandins, based on BPs. Four isolates, one C. glabrata, one C. rugosa, and two S. cerevisiae, were NWT for all three echinocandins. Two isolates, one C. albicans, and one C. rugosa, were NWT for MCA and ANI. One isolate of C. krusei and one of S. cerevisiae were NWT for CAS and ANI. Fifteen isolates, 13 C. krusei, one C. tropicalis, and one C. lambica, were NWT only for ANI. The two C. glabrata and C. tropicalis isolates, and one C. rugosa isolate also had high voriconazole MICs of 8.0, 2.0, and 0.5 mg/l, respectively. All 14 C. krusei isolates were WT for voriconazole. The other five isolates had low voriconazole MICs, below 0.12 mg/l.
Fungicidal activity (MFC/MIC ≤ 4)
Overall and against most species, the most fungicidal echinocandin was ANI with MFC/MIC ≤ 4 against 68.3% of the Candida isolates, followed by MCA with 55.5%, and CAS with 47.8% (Fig. 1) . All echinocandins had fungicidal activity most often at low concentrations ( Fig. 2) : MIC ≤ 0.12 mg/l and MFC ≤ 0.5 mg/l (see Figs. S3-S9, too, in supplementary files). The fungicidal activity occurred often at higher concentrations against C. parapsilosis (Fig. S4) , C. lusitaniae (Fig. S9) , rare Candida species, and S. cerevisiae. Against C. parapsilosis and C. kefyr, CAS was fungicidal most often at lower concentrations than MCA and ANI (Figs. S4, S8 ). Although they had equal percentages against C. glabrata, MCA was fungicidal at lower concentrations compared with ANI (Fig. S5) .
Against the 15 isolates NWT for CAS, the most fungicidal echinocandin was CAS itself (46.7%), followed by MCA (40.0%) and ANI (40.0%) (Fig. 3) . Against the 35 isolates NWT for MCA, the most fungicidal echinocandin was ANI (71.4%), followed by MCA (60.0%) and CAS (48.6%) (Fig. 4) . Against the 55 isolates NWT for ANI, the most fungicidal echinocandin was ANI itself (78.2%), followed by MCA (58.2%) and CAS (40.0%) (Fig. 5) .
In most cases where echinocandins did not have fungicidal activity, the MICs were below 012 mg/l and the MFCs were in the 0.12-2.0 mg/l range. This tendency did not apply to isolates of C. parapsilosis, C. guilliermondii, and rare Candida species.
Discussion
Owing to their potent antifungal effect and their low toxicity, echinocandins quickly became the antifungals of choice for the treatment or even prophylaxis of invasive fungal infections. 19, 20 Recent surveys, however, report an increasing frequency of resistant isolates, especially of C. glabrata. For Romania, this is the first study of the echinocandin susceptibility profile of a large collection of yeast isolates collected from sterile and nonsterile sites. The inconsistence of CAS antifungal testing results across different laboratories is well documented and has precluded EUCAST from establishing any breakpoints. The MICs obtained in the present study, however, were consistently lower by at least 1-2 log2 dilutions compared with other European reports. [21] [22] [23] [24] [25] [26] Only a recent GermanAustrian investigation published lower MIC values for C. glabrata 27 and a Spanish study for C. lusitaniae. 22 Similar to other reports, 7, 28 our results showed CAS to be active against C. parapsilosis and C. kefyr at lower concentrations, compared with MCA and ANI. The MIC modes and the geometric means presented in table S1 confirm the statements in version 8.0 of the EUCAST breakpoint tables regarding the differences between the MICs of MCA against C. albicans and those against C. krusei and C. tropicalis of three and 1-2 log2 dilutions, respectively 15 (see supplementary files). The differences of eight log2 dilutions between C. albicans and C. guilliermondii, however, were not confirmed. The MICs of our C. guilliermondii isolates were five log2 dilutions higher at most. Compared to a Spanish study that tested an extensive collection of Candida isolates, our MICs for MCA were comparable against C. albicans, C. glabrata, and C. tropicalis, lower against C. krusei and C. guilliermondii, and higher against C. parapsilosis, C. lusitaniae and C. kefyr. 22 In the case of ANI, our MICs were comparable against C. albicans and C. parapsilosis but higher against C. glabrata, C. tropicalis, C. lusitaniae, and C. kefyr. Similar to MCA, we obtained lower MICs for ANI against C. krusei and C. guilliermondii. In our study, the rare Candida species that showed potential for elevated echinocandin MICs were C. pelliculosa, C. rugosa, C. lipolytica, C. pulcherrima, C. famata, C. haemulonii, C. intermedia, and C. lambica, some of them confirming other reports. 26, 28 Isolates of C. lipolytica and C. pulcherrima also showed potential for high MFC values. With the exception of Lodderomyces elongisporus, all the non-Candida yeasts showed potential for high echinocandin MICs, confirming literature data. 29 Magnusiomyces capitatus in particular had clearly high MIC and MFC values. The ST isolates had significantly higher MIC and MFC values compared to the NST isolates. The reason is the difference in species distribution. The yeasts collected from normally sterile sites had a much lower proportion of C. albicans, a species which is naturally susceptible to echinocandins, and a much higher proportion of C. parapsilosis and C. guilliermondii, species with reduced susceptibilities. Compared with other European reports regarding isolates from sterile sites, the same trends described above apply: our MICs were lower for CAS, comparable for MCA and often higher for ANI, and all echinocandins had lower MICs against C. guilliermondii. [23] [24] [25] [26] To separate isolates with high MIC values, we used thresholds derived from ECOFF values determined with the CLSI method for certain drug-bug combinations, in lack of EUCAST similar data. The reason for our modifications is that previous studies that compared the CLSI and EU-CAST antifungal susceptibility testing methods agreed on the fact that, for MCA and ANI, the EUCAST MICs tend to be one log2 dilution lower. 30, 31 This is also confirmed by the fact that ECOFF values published by EUCAST are most often one or two log2 dilutions lower than their CLSI counterparts. In the case of CAS, however, the results were contradictory. One study reported lower MIC values for the EUCAST method 30 while others reported higher MIC values, 31, 32 which is consistent with the problematic interlaboratory variability reported for CAS. 33 We therefore decided to use the actual CLSI ECOFF values in the case of CAS. The NWT rates in our isolates were higher than those reported by other European or worldwide surveys, especially in the case of "the big five." Although we used many nonstandard thresholds, 78.2% of the isolates NWT for ANI and 71.4% of the isolates NWT for MCA were separated based on EUCAST breakpoints; therefore, they are also resistant. Our study confirms the reports of increasing echinocandin resistance of C. glabrata. 7 It had the highest rates of NWT isolates, followed by C. tropicalis and C. albicans. Although C. krusei had a high percentage of resistance to ANI, 13 of the 14 resistant isolates were not clearly separated from the WT population, with MICs of only 0.12 mg/l, just above the breakpoint. Moreover, ANI had the highest percent of fungicidal activity against C. krusei isolates. C. parapsilosis had a low resistance rate, but it had the highest number of right censored MFC values (>8 mg/l) to all echinocandins.
Although the ST isolates had higher MICs, the NST yeasts had higher rates of NWT isolates, with C. glabrata as a marked exception. This is a worrying fact, as superficial mycoses are often sources for subsequent invasive fungal infections. 34 Both MCA and ANI were reported to be highly predictive surrogate markers for the antifungal activity of CAS. [35] [36] [37] In our case this was true for the susceptible isolates. Against most MCA and/or ANI susceptible isolates, CAS had low MICs as well. The reverse, however, was not true. In fact, CAS had low MICs against more than 60% of the MCA and/or ANI resistant isolates. We also run an analysis where we lowered the CLSI ECOFF values by one log2 dilution for CAS as well (data not shown). The situation was virtually the same with one marked exception consisting of C. parapsilosis, which had significantly more NWT isolates. Most probably those extra isolates are in fact WT, since an EUCAST ECOFF of 0.5 mg/l for CAS against this species is unlikely. It is possible that some of the differences between echinocandins are caused by the inadequacy of the CLSI derived thresholds for MICs obtained with the EUCAST method, especially in the case of CAS. This, however, is less likely in the case of the C. glabrata and C. albicans isolates with differences between MCA and ANI (WT for one and NWT for the other). Mutations that do not cause crossresistance to all three echinocandins were reported 9, 38, 39 and are a possible explanation for at least some of the differences, especially for isolates that were resistant to either MCA or ANI, but not both.
Our results confirm the EUCAST recommendation that isolates susceptible to MCA and ANI should be considered susceptible to CAS as well 15 but indicate that this rule of thumb should not be applied to resistant isolates. Resistance to echinocandins was just 1% lower than resistance to FLC. In our study, 44.7% of the isolates with echinocandin resistance were resistant to both MCA and ANI. Moreover, 36.2% of the isolates resistant to at least one echinocandin were also resistant to FLC, and 30.4% of the FLC resistant isolates were also resistant to at least one echinocandin. This multiple drug resistance is an alarming fact, considering that FLC has also a nonspecific BP, which covers species that, at the time of this article, cannot be included in an analysis of echinocandin resistance. Moreover, except for C. krusei, which is intrinsically resistant to FLC, the rates of echinocandin resistance of all the other four most prevalent Candida species were higher than those of FLC resistance. 10 The MFC was less frequently assessed and therefore less studied than the MIC as a descriptive parameter of the antifungal activity of echinocandins, especially on a large scale.
Moreover, there are no investigations on the differences between MFCs obtained at the end of CLSI testing and those at the end of EUCAST testing. Compared with a previous European study, 25 our MFC values for CAS against Candida species were comparable, but those against S. cerevisiae and G. candidum were lower. Compared to time-kill studies, the simpler procedure to determine the MFC makes it more suitable for describing large collections of clinical isolates. Our study found weak correlations between the MFCs of the three echinocandins and between the MFCs and the MICs of each echinocandin, which suggests that the factors responsible for the MFC values are multiple and at least partially different from those responsible for the MICs.
In an attempt to investigate MIC and MFC values, not just separately but also with regard to the relationship between the two, the fungicidal activity (that we defined as MFC/MIC ≤ 4) of the three echinocandins was analyzed. We considered that 0.06/0.016 may not be the same as 8.0/2.0 in terms of treatment outcome and therefore divided the various combinations of MFCs and MICs into five levels of fungicidal activity (groups 1-5) and five levels of nonfungicidal activity (groups 6-10). In general, MCA and ANI had the highest rates of fungicidal activity, usually above 50%. The fungicidal activity occurred most often at low concentrations, except against C. parapsilosis, C. guilliermondii and the rare species with high MICs. Although with lower percentages than MCA and ANI, CAS was fungicidal at lower concentrations against C. parapsilosis and C. kefyr, which is consistent with its lower MICs against these species.
The significance of the MFC values and of the MFC/MIC ratios of echinocandins for the therapeutic outcome is not established, although some suggested that the MFC may be more relevant than the MIC. 40 The effect of resistance inducing mutations on the MFC was not assessed either.
Research showed a marked influence of some of these mutations on the in vivo fungicidal activity. 41 Interestingly, our investigations showed ANI to be the most fungicidal against isolates that were NWT for ANI itself and for MCA but not against those that were NWT for CAS. This, coupled with the general fungicidal activity data, seems to suggest a higher similarity between the antifungal activities of ANI and MCA, than between each of the two and CAS.
In conclusion, this first survey of the susceptibility to echinocandins of pathogenic yeasts from Romania revealed alarming rates of resistance to echinocandins and significant multiple drug resistance to echinocandins and azoles. Our caspofungin MICs were lower than most European reports. The correlation between the MFCs and the MICs was weak suggesting multiple and at least partially different factors responsible for the variation of these two parameters. Anidulafungin and micafungin had high rates (>50%) of fungicidal activity (MFC/MIC ≤ 4).
Supplementary material
Supplementary data are available at MMYCOL online.
